Premium
FTS4‐01‐04: CHALLENGES IN USING CSF BIOMARKERS FOR OPERATIONALIZING THE NIA‐AA AD RESEARCH FRAMEWORK
Author(s) -
Mielke Michelle M.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2904
Subject(s) - biomarker , cerebrospinal fluid , operationalization , medicine , neurodegeneration , oncology , disease , neuroimaging , pathological , alzheimer's disease neuroimaging initiative , pathology , psychology , bioinformatics , dementia , biology , psychiatry , philosophy , epistemology , biochemistry
not available. PL-04-02 COMMUNICATION BETWEEN THE IMMUNE SYSTEM AND THE BRAIN Michal Schwartz, Weizmann Institute of Science, Rehovot, Israel. Contact e-mail: Michal.Schwartz@weizmann.ac.il Abstract not available.not available. EMERGING CONCEPTS IN BASIC SCIENCE SERIES EC-04 PANEL DISCUSSION EC-04-01 PANEL DISCUSSION Rashid Deane, Karl Herrup, Giovanni B. Frisoni, University of Rochester Medical Center, Rochester, NY, USA; Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong; Lab Alzheimer’s Neuroimaging & Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico, Fatebenefratelli, Brescia, Italy. Contact e-mail: Rashid_Deane@URMC. Rochester.edu Abstract not availablenot available